BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang HC, Yin WX, Jiang M, Han JY, Kuai XW, Sun R, Sun YF, Ji JL. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma. World J Gastroenterol 2023; 29(39): 5435-5451 [PMID: 37900996 DOI: 10.3748/wjg.v29.i39.5435]
URL: https://www.wjgnet.com/1948-0210/full/v29/i39/5435.htm
Number Citing Articles
1
乐平 丁. Advances in the Study of Exosomal MicroRNAs in Hepatocellular CarcinomaMedical Diagnosis 2025; 15(03): 275 doi: 10.12677/md.2025.153036
2
Weiping Su, Yangying Zhou, Xuanxuan Li, Kuo Kang, Hui Nie. Construction and Validation of a Novel Butyrylation-Related Gene Signature Related to Prognosis, Clinical Implications, and Immune Microenvironment Characterization of Hepatocellular CarcinomaACS Omega 2025; 10(4): 3375 doi: 10.1021/acsomega.4c06496
3
Hong T Lin, Antonio F Alvarez Castaneda, Somashekar G Krishna, Khalid Mumtaz. MicroRNAs in hepatocellular carcinoma treatment: Charting the path forwardWorld Journal of Gastroenterology 2024; 30(11): 1470-1474 doi: 10.3748/wjg.v30.i11.1470
4
Tianhao Tong, Wenhui Gao, Huiying Jian, Renyi Yang, Jingting Zhang, Kexiong Li, Puhua Zeng. The role and potential mechanisms of exosomes in the progression of hepatocellular carcinomaHolistic Integrative Oncology 2025; 4(1) doi: 10.1007/s44178-025-00171-7
5
Sulin Wu, Namrata Anand, Zhoubo Guo, Mingyang Li, Marcos Santiago Figueroa, Lauren Jung, Sarah Kelly, Joseph W. Franses. Bridging Immune Evasion and Vascular Dynamics for Novel Therapeutic Frontiers in Hepatocellular CarcinomaCancers 2025; 17(11): 1860 doi: 10.3390/cancers17111860
6
Raluca-Margit Szilveszter, Mara Muntean, Adrian Florea. Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An OverviewBiomolecules 2024; 14(6): 656 doi: 10.3390/biom14060656
7
Qian Xu, Jinhan Chen, Yi Liu, Jinsheng Yu, Fangmin Zhao, Qijin Shu. Exosomal crosstalk: the metastatic language of hepatocellular carcinomaFrontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1701305
8
Takeshi Suda. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargoWorld Journal of Gastroenterology 2024; 30(17): 2369-2370 doi: 10.3748/wjg.v30.i17.2369
9
Rong Su, Yong Du, Pan Tian, Weifang Ma, Yongfeng Hui, Shaoqi Yang. Single-cell and spatial transcriptomics reveal correlation between RNA methylation-related miRNA risk model and immune infiltration in hepatocellular carcinomaFrontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1553239
10
Prasanna Srinivasan Ramalingam, Muhammad Afzal, M. Arockia Babu, Rekha M. M., Samir Sahoo, Surya Nath Pandey, Haider Ali, Md Sadique Hussain, Gaurav Gupta, Janaki Ramaiah Mekala, Sivakumar Arumugam. Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistanceFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1683799
11
Neeraj Choudhary, Dinesh Kumar, Thakur Prava Jyoti, Md Moidul Islam, Suresh Babu Kondaveeti, Md Faiyazuddin, Thomas J. Webster. Alcohol-induced extracellular vesicle signatures: Exploring liquid biopsy biomarkers for early cancer detection and prognosisAdvances in Cancer Biology - Metastasis 2026; 16: 100176 doi: 10.1016/j.adcanc.2026.100176
12
Harshvardhan Raval, Sankha Bhattacharya. Early Detection, Precision Treatment, Recurrence Monitoring: Liquid Biopsy Transforms Colorectal Cancer TherapyCurrent Cancer Drug Targets 2025; 25(6): 586 doi: 10.2174/0115680096295070240318075023
13
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1